LP
CERE
LMR Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,133,181
| Closed | -$46.3M | – | 1056 |
|
|
2024
Q2 | $46.3M | Buy |
1,133,181
+207,063
| +22% | +$8.47M | 0.39% | 22 |
|
|
2024
Q1 | $39.1M | Buy |
926,118
+601,535
| +185% | +$25.4M | 0.4% | 24 |
|
|
2023
Q4 | $13.8M | Buy |
+324,583
| New | +$13.8M | 0.16% | 98 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$1.48M | – | 1306 |
|
|
2021
Q3 | $1.48M | Buy |
+50,000
| New | +$1.48M | 0.02% | 533 |
|
|
2021
Q2 | – | Sell |
-22,145
| Closed | -$304K | – | 1366 |
|
|
2021
Q1 | $304K | Buy |
+22,145
| New | +$304K | 0.01% | 731 |
|